Cardiac Rehabilitation: Current Review of the Literature and Its Role in Patients with Heart Failure

Current Treatment Options in Cardiovascular Medicine
Nishant P ShahHaitham Ahmed

Abstract

Cardiovascular (CV) disease remains the leading cause of death in the USA despite major advances in its treatment. With time, cardiac rehabilitation (CR) programs have gathered interest to help increase CV health and improve functional status after a CV event. Patients with heart failure have also been shown to benefit. In this review, we will evaluate the current literature showcasing the benefits of CR, particularly in patients with heart failure, discuss current limitations, and avenues for future investigation. Studies have shown that CR is beneficial in reducing morbidity, mortality, hospitalizations, activity-related symptoms, and increasing quality of life. Similar findings have also been observed in patients with heart failure who underwent CR in addition to optimal medical management. The positive effects of CR are well established in patients with coronary disease. Recent literature is also showing a trend to benefit in patients with heart failure, though much of the evidence is limited to patients with systolic dysfunction. Despite recommendations by professional societies, the use of CR remains underutilized. Further investigation is needed to better understand the impact of CR in heart failure. Moreover, strategies...Continue Reading

References

Aug 26, 1998·European Heart Journal·R WillenheimerB Israelsson
Jan 27, 1999·Coronary Artery Disease·R P WielengaW L Mosterd
Dec 28, 1999·Journal of Cardiopulmonary Rehabilitation·R ArenaR McCall
Apr 1, 2000·European Journal of Heart Failure·A Owen, L Croucher
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Oct 1, 1953·British Journal of Industrial Medicine·J N MORRIS, J A HEADY
Jan 20, 2004·BMJ : British Medical Journal·M F PiepoliUNKNOWN ExTraMATCH Collaborative
May 21, 2004·The New England Journal of Medicine·Michael R BristowUNKNOWN Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
Mar 9, 2005·The New England Journal of Medicine·John G F ClelandUNKNOWN Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Marvin A KonstamUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Sep 4, 2007·The American Journal of Medicine·Richard V Milani, Carl J Lavie
Feb 27, 2008·Archives of Internal Medicine·Lesley H CurtisKevin A Schulman
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Christopher M O'ConnorUNKNOWN HF-ACTION Investigators
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Kathryn E FlynnUNKNOWN HF-ACTION Investigators
Jun 27, 2009·Journal of the American College of Cardiology·Jose A SuayaDonald S Shepard
Aug 1, 2009·Journal of the American College of Cardiology·Todd M BrownUNKNOWN American Heart Association Get With The Guidelines Investigators
Feb 26, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Mark S SlaughterUNKNOWN HeartMate II Clinical Investigators
Mar 18, 2010·American Journal of Health Promotion : AJHP·Anna SilbermanDean Ornish
Jul 8, 2011·The Cochrane Database of Systematic Reviews·Balraj S HeranRod S Taylor
Aug 6, 2011·Heart Failure Reviews·Ken KailaD Ian Paterson
Oct 16, 2012·Journal of the American College of Cardiology·Steven J KeteyianUNKNOWN HF-ACTION Investigators
Oct 1, 2013·Current Heart Failure Reports·A Afşin OktaySanjiv J Shah
Feb 22, 2014·The American Journal of Medicine·Shannon M DunlayVéronique L Roger
Mar 25, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Dalane W KitzmanMark Haykowsky
May 29, 2014·JAMA : the Journal of the American Medical Association·Marco PahorUNKNOWN LIFE study investigators
Jul 1, 2014·Heart Failure Clinics·Mark J Haykowsky, Dalane W Kitzman
Dec 10, 2014·European Journal of Preventive Cardiology·Patricia PalauJulio Núñez
Jan 31, 2015·Journal of the American College of Cardiology·Pratik B SandesaraLaurence Sperling
May 16, 2015·Journal of the American College of Cardiology·Krishna G AragamHitinder S Gurm
Jun 20, 2015·Journal of the American College of Cardiology·Daniel E FormanUNKNOWN American College of Cardiology’s Prevention of Cardiovascular Disease Section

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses
B A Goodwin
Journal of Cardiopulmonary Rehabilitation and Prevention
Karam I Turk-AdawiDonald S Shepard
© 2022 Meta ULC. All rights reserved